作者: Alexander Kretschmer , Tilman Todenhöfer
DOI: 10.1007/S00120-020-01381-9
关键词:
摘要: In recent years there have been substantial changes in the therapeutic landscape for systemic treatment of advanced prostate cancer (PCa), which resulted a multitude novel options different stages disease. current narrative review currently available metastatic hormone-sensitive PCa as well nonmetastatic castration-resistant are presented. addition, sequence and targeted stage highlighted.